Mr. Johnston focuses his practice on the preparation, prosecution, licensing, and litigation of patents, as well as counseling on intellectual property matters, with a particular focus in the pharmaceutical and biotechnology industries.
Prior to joining Gibbons, Mr. Johnston served as Vice President & Chief Patent Counsel at Hoffmann-La Roche Inc., a major healthcare organization, having ascended through the ranks from Patent Counsel. At Roche, Mr. Johnston developed and implemented a variety of strategies to strengthen the company’s intellectual property throughout the life cycle of its products. For several important pharmaceuticals, he enabled Roche to maintain lawful exclusivity for 20 years and beyond, and he won or settled the majority of the company’s patent litigations, ensuring marketing exclusivity and corresponding sales and licensing royalties worth billions of dollars. He negotiated and prepared the company’s first successful co-promotion alliance agreement, leading to half a billion dollars in revenue. Mr. Johnston was also extensively involved in legislative activities benefiting the pharmaceutical industry. Most notably, he helped negotiate and lobby Congress to pass both the Hatch-Waxman Act (and led Roche’s successful efforts to obtain one of the first resulting patent extensions) and Process Patent Amendments Act. In addition, his creative approach for petitioning the FDA led to Roche becoming one of the first companies to obtain pediatric exclusivity rights.
Rutgers School of Law – Newark|Stevens Institute of Technology
J.D.|Bachelor of Engineering – Chemical, with high honors
|
|
State of New Jersey|State of New York|United States Patent & Trademark Office
||
Named to IAM Global Leaders list – 2021
Named to IAM Patent 1000 – The World’s Leading Patent Practitioners
AV® Peer Review Rated by Martindale-Hubbell
Biotechnology Industry Organization (BIO) and Predecessor Organization
Patent Law Committee: First Chairperson
Intellectual Property Owners Association (IPO)
Former Member, Board of Directors
American Conference Institute
“Maximizing Pharmaceutical Patent Life Cycles” Conference: Co-Chair
Hatch Waxman Act: Board of Advisors
New Jersey Inventors Hall of Fame
Board of Trustees
Gibbons Institute of Law, Science, and Technology
Board of Advisors
Stevens Institute of Technology
Former Member, Board of Trustees and Executive Committee